Top Hamas leader doubles down on continued hostilities, boasts that group has crushed IDF


A prerecorded message published Tuesday by top Hamas figure Mohammed Deif committed the terror group to continuing the current hot conflict against Israel until a range of demands - long considered non-starters by Israel, Egypt, and the Palestinian Authority - were met. The segment, broadcast over Hamas's official television station, had Deif bragging that Hamas had defeated the Israeli Defense Forces, and more specifically that "the balance of power has changed. We have beaten the military. It is defeated." Deif also boasted that fighters organized by Hamas were ready to continuing attacking Israeli positions, boasting that "the IDF stands before united factions and soldiers who yearn for death." The Israelis for their part have emphasized that they will continue operating inside the Hamas-controlled Gaza Strip until they have successfully neutralized the organization's offensive tunnels, which snake from Gaza Strip civilian infrastructure to within a few dozen meters of Israeli border communities. The New York Times on Monday conveyed remarks from Israeli Prime Minister Benjamin Netanyahu declaring that the Jewish state will "not complete the operation without neutralizing the tunnels, the sole purpose of which is the destruction of our civilians and the killing of our children" and that "it cannot be that the citizens of the state of Israel will live under the deadly threats of missiles and infiltration through tunnels - death from above and death from below." The Israelis have gone to significant lengths to emphasize that their primary strategic goal remains the destruction of Hamas's offensive tunnel infrastructure, and it remains unclear to what degree Israeli leaders intend to commit ground forces against Hamas's rocket arsenal. Any effort to erode those assets will be complicated by the degree to which Hamas has embedded them in civilian infrastructure. The United Nations Relief and Works Agency (UNRWA) revealed today that it had found Hamas ordnance in one of its schools, marking the third announcement of its kind during the current Operation Protective Edge.


Macrocure, a late-stage Israeli biotech developing white blood cell injections to treat hard-to-heal and chronic wounds, has announced terms for its $75 million IPO. The Petach Tikva company is offering 5.4 million shares, according to Renaissance Capital Investments.  Macrocure’s main product is CureXcell, a cell based therapy that when applied to a wound, restores the natural balance required for the wound healing process. CureXcell has been approved as a medical device in Israel and has been used in more than 5,000 patients in commercial or clinical study settings with consistent results, according to Macrocure data. (via Israel21c)

Be the first to comment

Please check your e-mail for a link to activate your account.